Video Shorts
0:55
What Were Some of the Notable Takeaways From the 2026 ASCO Annual Meeting?
8 hours ago
by
Ravi B. Parikh, MD, MPP, FACP
1:53
Highlighting Brain Cancer Radiation Strategies and Needs for World Brain Tumor Day
a day ago
by
Raj Singh, MD
1:30
Daraxonrasib Represents a Major Breakthrough for Pancreatic Cancer Care
2 days ago
by
Tanios S. Bekaii-Saab, MD
1:11
Unpacking the NEXUS-01 Data in Bladder Cancer
5 days ago
by
Gopa Iyer, MD
1:00
RASolute 302 Read Out Marks An Exciting New Chapter in Pancreatic Cancer Care
5 days ago
by
Vincent J. Picozzi, MD
0:50
Aglatimagene Besadenovec Emerges in Prostate Cancer
6 days ago
by
Mark Garzotto, MD
1:07
Giants of Cancer Care 2026
11 days ago
by
Jonathan Lee, MD, MSc(+1 more)
3:51
Recapping the ASCO 2026 OncLive Fellows Forum: Lung Cancer
11 days ago
by
Chinmay Jani, MD
1:30
The “Million-Dollar Question”: Can Romiplostim Improve Outcomes by Maintaining Chemo Dose Intensity?
11 days ago
by
Gerald Soff, MD
0:36
An Analysis of Urinary Proteomics in Bladder Cancer
12 days ago
by
Mark Farha, MD
0:50
Investigating TTFields in Newly Diagnosed Glioblastoma
13 days ago
by
David Tran, MD, PhD
0:39
How Is AI Changing GU Cancer Surgery?
13 days ago
by
David Chen, MD
1:06
Inside the Science Behind Personalized Vaccine Development for Pancreatic Cancer
13 days ago
by
Paul E. Oberstein, MD
1:04
Previewing Updated Data From ASCENT-03 and ASCENT-04 Upcoming at ASCO 2026
14 days ago
by
Jane L. Meisel, MD
1:08
Raising Bladder Cancer Awareness
14 days ago
by
Ashish M. Kamat, MD
1:41
Previewing ASCO 2026: SUCCESSOR-2 Trial in R/R Multiple Myeloma
14 days ago
by
Rahul Banerjee, MD
3:58
OncLive News Roundup for the Week of 5/17
17 days ago
by
Chris Ryan
1:48
Previewing Key Breast Cancer Abstracts to Watch at ASCO 2026
19 days ago
by
Kevin Kalinsky, MD, MS
1:05
Breaking Down Mogamulizumab-Associated Rashes in CTCL
19 days ago
by
Stefan K. Barta, MD, MS
1:14
Previewing ASCO 2026: SENTRY, RALLY-MF Trials Represent Key MPN Abstracts
19 days ago
by
Anthony M Hunter, MD
0:54
Pancreatic Cancer Vaccines Aim to Bolster Long-Term Disease Control
20 days ago
by
Paul E. Oberstein, MD
1:27
Previewing ASCO 2026: Myeloma Abstracts to Watch
20 days ago
by
Diana Cirstea, MD
2:24
Live From AUA 2026: Interviewees Share Notable Data in GU Cancers
21 days ago
by
Kyle Doherty
1:34
Previewing ASCO 2026: Key MPN Presentations to Watch
21 days ago
by
Andrew Kuykendall, MD
0:57
What Are Experts Doing in DC Besides Attending the 2026 AUA Annual Meeting?
22 days ago
by
Kyle Doherty
0:53
Discussing Findings From a Post Hoc Analysis of DAROL in Prostate Cancer
22 days ago
by
Murilo De Almeida Luz, MD
1:00
Why There’s Still No Clear Treatment Roadmap for Treatment Sequencing in NETs
22 days ago
by
Andrew E. Hendifar, MD
0:57
Unpacking the PSA End Points of PSMAddition in Prostate Cancer
22 days ago
by
Fred Saad, CQ, MD, FRCS, FCAHS
4:10
OncLive News Roundup for the Week of 5/10
22 days ago
by
Chris Ryan(+1 more)
1:19
What Are the Biggest Unanswered Questions That Will Be Addressed at AUA 2026?
23 days ago
by
Kyle Doherty
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
3
GU Cancer Experts Highlight the Most Impactful and Discussion-Worthy Data Presented at ASCO 2026
4
Subcutaneous Isatuximab Administered Via OBI Approved in EU for Multiple Myeloma
5